Hecker Fink Files Amicus Brief in the U.S. Supreme Court on behalf of Former Military Officials, Former Civilian National Security Leaders, and Vet Voice Foundation in Danco Laboratories, L.L.C. v. Louisiana and GenBioPro, Inc. v. Louisiana
On May 7, 2026, Hecker Fink LLP filed a brief in the Supreme Court of the United States on behalf of former military officials, former civilian national security leaders, and Vet Voice Foundation in Danco Laboratories, L.L.C. v. Louisiana and GenBioPro, Inc. v. Louisiana, Nos. 25A1207 and 25A1208. The brief supports emergency applications by Danco Laboratories and GenBioPro to stay or vacate the Fifth Circuit's stay of the 2023 REMS regulation governing mifepristone access.
The brief expands upon the amicus brief Hecker Fink previously filed on behalf of Vet Voice Foundation at the U.S. Court of Appeals for the Fifth Circuit. This Supreme Court filing includes eight individual signatories who are high-ranking military veterans and former civilian national security leaders. The signatories bring decades of expertise in military recruitment, readiness, medical care, and personnel matters. They include Secretaries of the Army and Air Force, retired Major Generals and Brigadier Generals, and other senior defense leaders who held command and policy positions at the highest levels of the U.S. military.
The brief argues that reinstating the in-person dispensing requirement for mifepristone would directly harm military readiness by undermining recruitment, increasing attrition, and disrupting unit cohesion. Women comprise around 18 percent of the active-duty military, and access to comprehensive reproductive healthcare is critical to maintaining the readiness upon which the Nation's security depends. Telehealth access to mifepristone helps preserve personnel availability by enabling servicemembers to obtain essential healthcare without extended travel or disruption to their duties.
The Hecker Fink Team includes Clara Spera, Kate Epstein, Maddie Verniero, and Amelia Levitt-Smith.
Read the full brief here.